Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

70 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of atorvastatin and bezafibrate on plasma levels of C-reactive protein in combined (mixed) hyperlipidemia.
Gómez-Gerique JA, Ros E, Oliván J, Mostaza JM, Vilardell M, Pintó X, Civeira F, Hernández A, da Silva PM, Rodriguez-Botaro A, Zambón D, Lima J, Díaz C, Aristegui R, Sol JM, Chaves J, Hernández G; ATOMIX Investigators. Gómez-Gerique JA, et al. Among authors: olivan j. Atherosclerosis. 2002 Jun;162(2):245-51. doi: 10.1016/s0021-9150(01)00708-0. Atherosclerosis. 2002. PMID: 11996943 Clinical Trial.
Atorvastatin versus Bezafibrate in Mixed Hyperlipidaemia : Randomised Clinical Trial of Efficacy and Safety (the ATOMIX Study).
Ros E, Oliván J, Mostaza JM, Vilardell M, Pintó X, Civeira F, Hernández A, Marqués da Silva P, Rodriguez-Botaro A, Zambón D, Lima J, Gómez-Gerique JA, Díaz C, Arístegui R, Sol JM, Hernández G. Ros E, et al. Among authors: olivan j. Clin Drug Investig. 2003;23(3):153-65. doi: 10.2165/00044011-200323030-00002. Clin Drug Investig. 2003. PMID: 23340922
[Stable peaks and far field potentials].
Oliván J. Oliván J. Arch Neurobiol (Madr). 1990 Jul-Aug;53(4):149-50. Arch Neurobiol (Madr). 1990. PMID: 2090017 Review. Spanish. No abstract available.
Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs.
Santamarina E, Bertol V, Garayoa V, García-Gomara MJ, Garamendi-Ruiz I, Giner P, Aranzábal I, Piera A, Arcos C, Esteve P, Marinas A, García-Escrivá A, Viloria-Alebesque A, Loro FA, de Tienda AP, Olivan JA, Bonet M, Dávila-González P, Sivera R, Molins A, Sansa G, Roche JC, Martínez AB, Monteagudo S, Casadevall T. Santamarina E, et al. Among authors: olivan ja. Seizure. 2020 Dec;83:48-56. doi: 10.1016/j.seizure.2020.09.026. Epub 2020 Oct 7. Seizure. 2020. PMID: 33096456 Free article.
Concurrent Exercise Interventions in Breast Cancer Survivors with Cancer-related Fatigue.
Pagola I, Morales JS, Alejo LB, Barcelo O, Montil M, Oliván J, Álvarez-Bustos A, Cantos B, Maximiano C, Hidalgo F, Valenzuela PL, Fiuza-Luces C, Lucia A, Ruiz-Casado A. Pagola I, et al. Among authors: olivan j. Int J Sports Med. 2020 Oct;41(11):790-797. doi: 10.1055/a-1147-1513. Epub 2020 Jun 29. Int J Sports Med. 2020. PMID: 32599641 Clinical Trial.
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Riesmeyer JS, Riddle MC, Rydén L, Xavier D, Atisso CM, Dyal L, Hall S, Rao-Melacini P, Wong G, Avezum A, Basile J, Chung N, Conget I, Cushman WC, Franek E, Hancu N, Hanefeld M, Holt S, Jansky P, Keltai M, Lanas F, Leiter LA, Lopez-Jaramillo P, Cardona Munoz EG, Pirags V, Pogosova N, Raubenheimer PJ, Shaw JE, Sheu WH, Temelkova-Kurktschiev T; REWIND Investigators. Gerstein HC, et al. Lancet. 2019 Jul 13;394(10193):121-130. doi: 10.1016/S0140-6736(19)31149-3. Epub 2019 Jun 9. Lancet. 2019. PMID: 31189511 Clinical Trial.
70 results